You just read:

Keryx Biopharmaceuticals Announces New Drug Application Submission for Zerenex™ for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

News provided by

Keryx Biopharmaceuticals, Inc.

08 Aug, 2013, 13:30 BST